Skip to main content
main-content

2015 | OriginalPaper | Buchkapitel

7. Kopfschmerz

verfasst von: Martina Sendera, Alice Sendera

Erschienen in: Chronischer Schmerz

Verlag: Springer Vienna

Zusammenfassung

Man unterscheidet aktuell 228 Formen von Kopfschmerz, unterteilt in 14 Unterkapitel. Ein sehr großer Anteil an Kopfschmerzen kann alleine durch ein ausführliches Anamnese-Gespräch diagnostiziert oder in Richtung einer bestimmten Kopfschmerzform eingeengt werden. Bei neuen Symptomen oder Veränderung bestehender Symptome muss auch bei jahrelanger Kopfschmerzanamnese eine neuerliche Diagnostik durchgeführt werden! Von größter Bedeutung ist die Differenzierung zwischen primären und sekundären Kopfschmerzen.
Fußnoten
1
Wir bedanken uns bei Herrn Dr. Martin Pinsger, Facharzt für Orthopädie und orthopädische Chirurgie, Bad Vöslau und Privatklinik Josefstadt, Wien, für seinen Erfahrungsbericht mit lokaler Opioidanalgesie
 
Literatur
Zurück zum Zitat Ashina M, Lassen LH, Bendtsen L, Jensen R, Olesen J (1999) Effect of inhibition of nitiric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet 1999; 353: 287–289 CrossRefPubMed Ashina M, Lassen LH, Bendtsen L, Jensen R, Olesen J (1999) Effect of inhibition of nitiric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet 1999; 353: 287–289 CrossRefPubMed
Zurück zum Zitat Bartolini M, Silvestrini M, Taffi R, Lanciotti C, Luconi R, Capecci M, Provinciali L (2005) Efficacy of topiramate and valproate in chronic migraine. Clin Neuropharmacol 2005; 28(6): 277–279 CrossRefPubMed Bartolini M, Silvestrini M, Taffi R, Lanciotti C, Luconi R, Capecci M, Provinciali L (2005) Efficacy of topiramate and valproate in chronic migraine. Clin Neuropharmacol 2005; 28(6): 277–279 CrossRefPubMed
Zurück zum Zitat Burstein R, Collins B, Jakubowski M (2004) Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004; 55: 19–26 CrossRefPubMed Burstein R, Collins B, Jakubowski M (2004) Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004; 55: 19–26 CrossRefPubMed
Zurück zum Zitat Chang Cl, Donaghy M, Poulter N (1999) Migraine and stroke in young women: case-control study: The World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormon Contraceptation. BMJ 1999, 318: 13–18 CrossRefPubMedCentralPubMed Chang Cl, Donaghy M, Poulter N (1999) Migraine and stroke in young women: case-control study: The World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormon Contraceptation. BMJ 1999, 318: 13–18 CrossRefPubMedCentralPubMed
Zurück zum Zitat Descombes S, Brefel-Courbon C, Thalamas C, Albucher JF, Rascol O, Montastruc JL, Senard J M (2001) Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study. Headach 2001; 41: 178–182 CrossRef Descombes S, Brefel-Courbon C, Thalamas C, Albucher JF, Rascol O, Montastruc JL, Senard J M (2001) Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study. Headach 2001; 41: 178–182 CrossRef
Zurück zum Zitat Diener HC, Dodick DW, Aurora SK et al. (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010 Jul; 30(7): 804–14 CrossRefPubMed Diener HC, Dodick DW, Aurora SK et al. (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010 Jul; 30(7): 804–14 CrossRefPubMed
Zurück zum Zitat Dowson AJ, Dodick DW, Limmroth V (2005) Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis. CNS Drugs 2005; 19(6): 483–97 CrossRefPubMed Dowson AJ, Dodick DW, Limmroth V (2005) Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis. CNS Drugs 2005; 19(6): 483–97 CrossRefPubMed
Zurück zum Zitat Edwards KR, Norton J, Behnke M (2001) Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache 2001; 41: 976–80 CrossRefPubMed Edwards KR, Norton J, Behnke M (2001) Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache 2001; 41: 976–80 CrossRefPubMed
Zurück zum Zitat Evers S, Gralow I, Bauer B, Suhr B, Buchheister A, Husstedt IW, Ringelstein EB (1999) Sumatriptan and ergotamine overuse and drug-induced headache: a clinicoepidemiologic study. Clin Neuropharmacol 1999; 22: 201–206 PubMed Evers S, Gralow I, Bauer B, Suhr B, Buchheister A, Husstedt IW, Ringelstein EB (1999) Sumatriptan and ergotamine overuse and drug-induced headache: a clinicoepidemiologic study. Clin Neuropharmacol 1999; 22: 201–206 PubMed
Zurück zum Zitat Ferrari MD (1999) How to assess and compare drugs in the management of migraine: success rates in terms of response and recurrence. Cephalalgia 1999; 19 Suppl 23: 2–8 PubMed Ferrari MD (1999) How to assess and compare drugs in the management of migraine: success rates in terms of response and recurrence. Cephalalgia 1999; 19 Suppl 23: 2–8 PubMed
Zurück zum Zitat Fogelholm R, Murros K (1992). Tizanidine in chronic tension-type headache: a placebo controlled, double-blind cross over study. Headache 1992; 32: 509–513 CrossRefPubMed Fogelholm R, Murros K (1992). Tizanidine in chronic tension-type headache: a placebo controlled, double-blind cross over study. Headache 1992; 32: 509–513 CrossRefPubMed
Zurück zum Zitat Freitag FG, Diamond S, Diamond ML, Urban GJ (2001) Divalproex in the long-term treatment of chronic daily headache. Headache 2001; 41(3): 271–278 CrossRefPubMed Freitag FG, Diamond S, Diamond ML, Urban GJ (2001) Divalproex in the long-term treatment of chronic daily headache. Headache 2001; 41(3): 271–278 CrossRefPubMed
Zurück zum Zitat Frietsche G, Diener H (2002) Medication overuse headaches – what is new? Expert Opin Drug Saf 1(4): 331–338 CrossRef Frietsche G, Diener H (2002) Medication overuse headaches – what is new? Expert Opin Drug Saf 1(4): 331–338 CrossRef
Zurück zum Zitat Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK (2008) Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet. 2008; 372: 2115–2123 CrossRefPubMed Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK (2008) Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet. 2008; 372: 2115–2123 CrossRefPubMed
Zurück zum Zitat Holroyd KA, O’Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW (2001) Management of chronic tension-type headache with tricyclic anti-depressant medication, stress management therapy and their combination. JAMA 2001; 285: 2208–2215 CrossRefPubMedCentralPubMed Holroyd KA, O’Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW (2001) Management of chronic tension-type headache with tricyclic anti-depressant medication, stress management therapy and their combination. JAMA 2001; 285: 2208–2215 CrossRefPubMedCentralPubMed
Zurück zum Zitat Jensen R (1999) Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies. Cephalalgia 1999; 19: 602–621 CrossRefPubMed Jensen R (1999) Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies. Cephalalgia 1999; 19: 602–621 CrossRefPubMed
Zurück zum Zitat Juang KD, Wang SJ, Fuh JL, Lu SR, Su TP (2000) Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 2000; 40: 818–823 CrossRefPubMed Juang KD, Wang SJ, Fuh JL, Lu SR, Su TP (2000) Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 2000; 40: 818–823 CrossRefPubMed
Zurück zum Zitat Katsarava Z, Jensen R (2007) Medication overuse headache: where are we now? Curr Opin Neurol 2007; 20: 326–330 CrossRefPubMed Katsarava Z, Jensen R (2007) Medication overuse headache: where are we now? Curr Opin Neurol 2007; 20: 326–330 CrossRefPubMed
Zurück zum Zitat Knapp TW (1983) Migräne Bd. 1: Symptomatologie und Ätiologie. Beltz, Weinheim Knapp TW (1983) Migräne Bd. 1: Symptomatologie und Ätiologie. Beltz, Weinheim
Zurück zum Zitat Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ (2004) Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain 2004; 127: 220–30 CrossRefPubMed Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ (2004) Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain 2004; 127: 220–30 CrossRefPubMed
Zurück zum Zitat Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C (2005) BOTOX CDH Study Group. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 2005; 45(4): 293–307 CrossRefPubMed Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C (2005) BOTOX CDH Study Group. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 2005; 45(4): 293–307 CrossRefPubMed
Zurück zum Zitat Moja PL, Cusi C, Sterzi RR, Canepari C (2005) Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev 2005; 3 Moja PL, Cusi C, Sterzi RR, Canepari C (2005) Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev 2005; 3
Zurück zum Zitat Olesen J, Bousser MG, Diener H et al. (2004) The International Classification of Headache Disorders. 2nd Edition. Cephalalgia 2004; 24 (Suppl 1): 1–160 CrossRef Olesen J, Bousser MG, Diener H et al. (2004) The International Classification of Headache Disorders. 2nd Edition. Cephalalgia 2004; 24 (Suppl 1): 1–160 CrossRef
Zurück zum Zitat Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ, for the Headache Classification Committee (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26(6): 742–746 CrossRefPubMed Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ, for the Headache Classification Committee (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26(6): 742–746 CrossRefPubMed
Zurück zum Zitat Paemeleire K, Bahra A, Evers S, Matharu MS, Goadsby PJ (2006) Medication-overuse headache in patients with cluster headache. Neurology 67(1): 109–13 CrossRefPubMed Paemeleire K, Bahra A, Evers S, Matharu MS, Goadsby PJ (2006) Medication-overuse headache in patients with cluster headache. Neurology 67(1): 109–13 CrossRefPubMed
Zurück zum Zitat Panksepp J (1998) Affective Neuroscience: The Foundations of Human and Animal Emotions. New York: Oxford University Press Panksepp J (1998) Affective Neuroscience: The Foundations of Human and Animal Emotions. New York: Oxford University Press
Zurück zum Zitat Patel NV, Bigal ME, Kolodner KB (2004) Prevalence and inpact of migraine and probable migraine in a health plan. Neurology 27: 163–181 Patel NV, Bigal ME, Kolodner KB (2004) Prevalence and inpact of migraine and probable migraine in a health plan. Neurology 27: 163–181
Zurück zum Zitat Penzien DB, Rains JC, Andrasik F (2002) Behavioral management of recurent headache: three decades of experience empiricism. Appl Psychophhysiol Biofeedback 27: 948–951 Penzien DB, Rains JC, Andrasik F (2002) Behavioral management of recurent headache: three decades of experience empiricism. Appl Psychophhysiol Biofeedback 27: 948–951
Zurück zum Zitat Peres MF, Silberstein SD, Nahmias S, Shechter AL, Youssef I, Rozen TD, Young WB (2000) Hemicrania continua is not that rare. Neurology 2000; 57(6): 948–51 CrossRef Peres MF, Silberstein SD, Nahmias S, Shechter AL, Youssef I, Rozen TD, Young WB (2000) Hemicrania continua is not that rare. Neurology 2000; 57(6): 948–51 CrossRef
Zurück zum Zitat Rasmusen BK (1993) Migraine and tension typ headache in a general population: precipitating factors, female hormones, sleep pattern and relation to life-style. Pain 1993; 53: 65–72 CrossRef Rasmusen BK (1993) Migraine and tension typ headache in a general population: precipitating factors, female hormones, sleep pattern and relation to life-style. Pain 1993; 53: 65–72 CrossRef
Zurück zum Zitat Rasmussen BK, Jensen R, Schroll M, Olesen J (1991) Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991; 44: 1147–1157 CrossRefPubMed Rasmussen BK, Jensen R, Schroll M, Olesen J (1991) Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991; 44: 1147–1157 CrossRefPubMed
Zurück zum Zitat Russel MB (2004) Epidemiology and genetics of cluster headache. Lancet Neurol 2004; 3: 279–283 CrossRef Russel MB (2004) Epidemiology and genetics of cluster headache. Lancet Neurol 2004; 3: 279–283 CrossRef
Zurück zum Zitat Sacks O (1996) Migräne. 8. Aufl., Rororo: Rowohlt: Berlin Sacks O (1996) Migräne. 8. Aufl., Rororo: Rowohlt: Berlin
Zurück zum Zitat Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F (2003) Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study The Lancet, Volume 361, Issue 9374, 14 June 2003, pp. 2046–2048 Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F (2003) Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study The Lancet, Volume 361, Issue 9374, 14 June 2003, pp. 2046–2048
Zurück zum Zitat Seng EK, Holroyd KA (2012) Psychiatric comorbidity and response to preventative therapy in the treatment of severe migraine trial. Cephalalgia. 2012; 32(5): 390–400 CrossRefPubMed Seng EK, Holroyd KA (2012) Psychiatric comorbidity and response to preventative therapy in the treatment of severe migraine trial. Cephalalgia. 2012; 32(5): 390–400 CrossRefPubMed
Zurück zum Zitat Serra G, Marchioretto F (2012) Occipital nerve stimulation for chronic migraine: a randomized trial. Pain Physician. 2012; 15: 245–53 PubMed Serra G, Marchioretto F (2012) Occipital nerve stimulation for chronic migraine: a randomized trial. Pain Physician. 2012; 15: 245–53 PubMed
Zurück zum Zitat Shapiro RE, Tepper SJ (2007) The Serotonin Syndrome, Triptans, and the Potential for Drug-Drug Interactions, Headache 2007; 47: 266–69 CrossRefPubMed Shapiro RE, Tepper SJ (2007) The Serotonin Syndrome, Triptans, and the Potential for Drug-Drug Interactions, Headache 2007; 47: 266–69 CrossRefPubMed
Zurück zum Zitat Silberstein SD et al. (2005) Tramadol/Acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial. Headache 2005; 45: 1317–1327 CrossRefPubMed Silberstein SD et al. (2005) Tramadol/Acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial. Headache 2005; 45: 1317–1327 CrossRefPubMed
Zurück zum Zitat Silvestrini M, Bartolini M, Coccia M, Baruffaldi R, Taffi R, Provinciali L (2006) Topiramate in the treatment of chronic migraine. Cephalalgia 2003; 23(8): 820–4 CrossRef Silvestrini M, Bartolini M, Coccia M, Baruffaldi R, Taffi R, Provinciali L (2006) Topiramate in the treatment of chronic migraine. Cephalalgia 2003; 23(8): 820–4 CrossRef
Zurück zum Zitat Sjaastad O, Stovner LJ, Stolt Nielsen A, Antonaci F, Fredriksen TA (1995) CPH and hemicrania continua: requirements of high indomethacin dosages – an ominous sign? Headache 1995; 35(6): 363–367 CrossRefPubMed Sjaastad O, Stovner LJ, Stolt Nielsen A, Antonaci F, Fredriksen TA (1995) CPH and hemicrania continua: requirements of high indomethacin dosages – an ominous sign? Headache 1995; 35(6): 363–367 CrossRefPubMed
Zurück zum Zitat Spierings ELH, Ranke AH, Schroevers M, Honkoop PC (2000) Chronic daily headachea time perspective. Headache 2000; 40: 306–310 CrossRefPubMed Spierings ELH, Ranke AH, Schroevers M, Honkoop PC (2000) Chronic daily headachea time perspective. Headache 2000; 40: 306–310 CrossRefPubMed
Zurück zum Zitat Spira PJ, Beran RG (2003) Australian Gabapentin Chronic Daily Headache Group. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology 2003; 61(12): 1753–9 CrossRefPubMed Spira PJ, Beran RG (2003) Australian Gabapentin Chronic Daily Headache Group. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology 2003; 61(12): 1753–9 CrossRefPubMed
Zurück zum Zitat Stein A et al. (1999) Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 1999; 83: 525–32 CrossRefPubMed Stein A et al. (1999) Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 1999; 83: 525–32 CrossRefPubMed
Zurück zum Zitat Stovner LJ et al. (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007; 27: 193–210 CrossRefPubMed Stovner LJ et al. (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007; 27: 193–210 CrossRefPubMed
Zurück zum Zitat Türp JC, Marinello CP (2002) Schmerzfragebogen für Patienten mit chronischen orofacialen Schmerzen. Quintessenz 29´002; 52: 1333–1340 Türp JC, Marinello CP (2002) Schmerzfragebogen für Patienten mit chronischen orofacialen Schmerzen. Quintessenz 29´002; 52: 1333–1340
Zurück zum Zitat Wiesinger B, Malker H, Englund E, Wänman A (2009) Does a dose-response relation exist between spinal pain and temporomandibular disorders? BMC Musculoskelet Disord 2009; 10: 28 CrossRefPubMedCentralPubMed Wiesinger B, Malker H, Englund E, Wänman A (2009) Does a dose-response relation exist between spinal pain and temporomandibular disorders? BMC Musculoskelet Disord 2009; 10: 28 CrossRefPubMedCentralPubMed
Zurück zum Zitat Wöber C (2013) Migräne – was ist neu, was ist relevant? Ärztekrone, 2: 35–36 Wöber C (2013) Migräne – was ist neu, was ist relevant? Ärztekrone, 2: 35–36
Zurück zum Zitat Wright EF (2000) Referred craniofacial pain patterns in patients with temporomandibular disorder. J Am Dent Assoc 2000; 131: 1307–1315 CrossRefPubMed Wright EF (2000) Referred craniofacial pain patterns in patients with temporomandibular disorder. J Am Dent Assoc 2000; 131: 1307–1315 CrossRefPubMed
Zurück zum Zitat Zebenholzer K, Rudel E, Frantal S, Brannath W, Schmidt K, Wöber-Bingöl C, Wöber C (2011) Migraine and weather: A prospective diary-based analysis. Cephalalgia vol. 31; 4: 391–400 Zebenholzer K, Rudel E, Frantal S, Brannath W, Schmidt K, Wöber-Bingöl C, Wöber C (2011) Migraine and weather: A prospective diary-based analysis. Cephalalgia vol. 31; 4: 391–400
Zurück zum Zitat Zwart JA, Dyb G, Hagen K, Svebak S, Stovner LJ, Holmen J (2004) Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology 2004; 62(9): 1540–4 CrossRefPubMed Zwart JA, Dyb G, Hagen K, Svebak S, Stovner LJ, Holmen J (2004) Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology 2004; 62(9): 1540–4 CrossRefPubMed
Metadaten
Titel
Kopfschmerz
verfasst von
Martina Sendera
Alice Sendera
Copyright-Jahr
2015
Verlag
Springer Vienna
DOI
https://doi.org/10.1007/978-3-7091-1841-2_7

Neu im Fachgebiet AINS

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update AINS und bleiben Sie gut informiert – ganz bequem per eMail.